Mortality trends during the first three waves of the COVID-19 pandemic at an urban district hospital in South Africa: A retrospective comparative analysis
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i2.1054Keywords:
COVID, COVID-19, COVID-19 inpatient, COVID-19 Waves, district hospitals, mortality trendsAbstract
Background. Severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) is the virus responsible for the COVID‐19 (C19) pandemic. South Africa (SA) experienced multiple periods of increased transmission. Tertiary, regional and central hospitals were overwhelmed, resulting in low acceptance rates.
Objectives. To compare mortality trends of patients who died in hospital from SARS‐CoV‐2 infection during the first three waves of infection as defined by the National Institute of Communicable Diseases of South Africa.
Methods. This was a retrospective cohort study at a district level hospital of 311 adults who died within the first three waves of COVID‐19. The study analysed case and crude fatality rates, baseline characteristics, symptomatology, clinical presentation and management of patients.
Results. Waves 1, 2 and 3 yielded case fatality rates of 14.5%, 27.6% and 6.3%, respectively, and crude fatality rates of 16.7%, 33.0% and 12.2%, respectively. Black Africans were less likely to die during the third wave (odds ratio (OR) 0.54; 95% confidence interval (CI) 0.31 ‐ 0.94). Patients in the second wave had clinical frailty scores of <5 (OR 2.51; 95% CI 1.56 ‐ 4.03). Obesity was most prevalent in the second wave (OR 1.87; 95% CI 1.01 ‐ 3.46), and dyslipidaemia (OR 3.03; 95% CI 1.59 ‐ 5.77) and ischaemic heart disease (OR 3.77; 95% CI .71 ‐ 8.33) were most prevalent during the third wave. Severe ground glass appearance was most common during the second wave (OR 2.37; 95% CI 1.49 ‐ 3.77). Renal impairment was most prevalent during the first wave (OR 3.28; 95% CI 1.59 ‐ 6.77), and thrombo‐ embolic phenomena were less common during wave three (OR 0.12; 95% CI 0.02 ‐ 0.91).
Conclusion. The Beta variant was the most virulent, with the highest case and crude fatality rates in wave 2.
References
Mendelson M, Boloko L, Boutall A, et al. Clinical management of COVID‐19: Experiences of the COVID‐19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J 2020;110(10):973‐981. https://doi.org/10.7196/SAMJ.2020.v110i10.15157
Ejaz H, Alsrhani A, Zafar A, et al. Covid‐19 and comorbidities: Deleterious impact on infected patients. J Infect Pub Health 2020;13(12):1833‐1839. https://doi.org/10.1016/j.jiph.2020.07.014
Pillay‐van Wyk V, Bradshaw D, Groenewald P. COVID deaths in South Africa: 99 days since South Africa’s first death. S Afr Med J 2020;110(11):1093. https://doi.org/10.7196/samj.2020.v110i11.15249 4. JassatW,CohenC,TempiaS,etal.RiskfactorsforCOVID‐19‐relatedin‐hospitalmortalityinahighHIV
and tuberculosis prevalence setting in South Africa: A cohort study. Lancet HIV 2021;8(9):e554‐e567.
https://doi.org/10.1016/S2352‐3018(21)00151‐X
Jassat W, Abdool Karim SS, Mudara C, et al. Clinical severity of COVID‐19 in patients admitted to hospital during the Omicron Wave in South Africa: A retrospective observational study. Lancet Glob Health 2022;10(7):e961‐e969. https://doi.org/10.1016/s2214‐109x(22)00114‐0
Arnold‐Day C, van Zyl‐Smit RN, Joubert IA, et al. Outcomes of patients with COVID‐19 acute respiratory distress syndrome requiring invasive mechanical ventilation admitted to an intensive care unit in South Africa. S Afr Med J 2021;27‐33. https://doi.org/10.7196/samj.2022.v112i1.16115
Nunes MC, Baillie VL, Kwatra G, et al. Severe acute respiratory syndrome coronavirus 2 infection among healthcare workers in South Africa: A longitudinal cohort study. Clin Infect Dis 2021;73(10):1896‐1900. https://doi.org/10.1093/cid/ciab398
Mash RJ, Presence‐Vollenhoven M, Adeniji A, et al. Evaluation of patient characteristics, management and outcomes for COVID‐19 at district hospitals in the Western Cape, South Africa: Descriptive observational study. BMJ Open 2021;11(1). https://doi.org/10.1136/bmjopen‐2020‐047016
Church S, Rogers E, Rockwood K, Theou O. A scoping review of the clinical frailty scale. BMC Geriatr 2020;20(1). https://doi.org/10.1186/s12877‐020‐01801‐7
KwaZulu‐Natal Department of Health. Referral system – levels of care. KZN Health. https://www. kznhealth.gov.za/Referral‐system.htm (accessed 3 January 2023).
NationalInstituteforCommunicableDiseases.ProposeddefinitionofCOVID‐19waveinSouthAfrica. Pretoria: NICD, 2021. https://www.nicd.ac.za/wp‐content/uploads/2021/11/Proposed‐definition‐of‐ COVID‐19‐wave‐in‐South‐Africa.pdf (accesed 16 September 2022).
TheSouthAfricanTriageScale(SATS).EmergencyMedicineSocietyofSouthAfrica,2019.https://emssa. org.za/special‐interest‐groups/the‐south‐african‐triage‐scale‐sats/ (accessed 11 March 2023).
Bekker L‐G, Ntusi NA. Lessons from two SARS‐COV‐2 waves in South Africa. Lancet Glob Health 2021;9(9):e1177‐e1178. https://doi.org/10.1016/s2214‐109x(21)00313‐2
Forchette L, Sebastian W, Liu T. A comprehensive review of COVID‐19 virology, vaccines, variants, and therapeutics. Curr Med Sci 2021;41(6):1037‐1051. https://doi.org/10.1007/s11596‐021‐2395‐1
National Institute for Communicable Diseases. Covid‐19 Hospital Surveillance Update: Week 22,
Pretoria: NICD, 2022. https://www.nicd.ac.za/wp‐content/uploads/2022/06/NICD‐COVID‐19‐
Weekly‐Sentinel‐Hospital‐Surveilance‐update‐Week‐22‐2022.pdf (accessed 10 March 2022).
Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with coronavirus disease 2019 (COVID‐19) infection: A systematic review and meta‐analysis of observational studies. The Aging Male 2020;23(5):1416‐1424. https://doi.org/10.1080/13685538.2
1774748
Abdalla S, Katz EG, Hartley A, Darmstadt GL. Gender and the impact of covid‐19 on demand for and access to health care: Intersectional analysis of before‐and‐after data from Kenya, Nigeria, and South Africa. J Glob Health 2022:12. https://doi.org/10.7189/jogh.12.05024
Statistics South Africa. Census 2016. Pretoria: Stats SA, 2016. http://cs2016.statssa.gov.za/ (accessed 14 March 2023).
Nglazi MD, Ataguba JE‐O. Overweight and obesity in non‐pregnant women of childbearing age in South Africa: Subgroup regression analyses of survey data from 1998 to 2017. BMC Pub Health 2022;22(1):395. https://doi.org/10.1186/s12889‐022‐12601‐6
Navaratnam AV, Gray WK, Day J, Wendon J, Briggs TW. Patient factors and temporal trends associated with COVID‐19 in‐hospital mortality in England: An observational study using administrative data. Lancet Respir Med 2021;9(4):397‐406. https://doi.org/10.1016/s2213‐2600(20)30579‐8
Nalbandian A, Sehgal K, Gupta A, et al. Post‐acute COVID‐19 syndrome. Nature Med 2021;27(4):601‐ 615. https://doi.org/10.1038/s41591‐021‐01283‐z
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID‐19: A consensus paper from the ESC Working Group on Coronary Pathophysiology and Microcirculation, ESC Working Group on thrombosis and the Association for Acute Cardiovascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021;117(14):2705‐2709. https://doi.org/10.1093/cvr/cvab298
National Department of Health. What does South Africa’s COVID vaccine roll‐out plan say? Pretoria: NDoH, 2021 https://sacoronavirus.co.za/2021/01/12/what‐does‐south‐africas‐covid‐vaccine‐roll‐out‐ plan‐say/ (accessed 12 October 2022).
Kumar G, Mukherjee A, Sharma R, et al. Clinical profile of hospitalized COVID‐19 patients in first and second wave of the pandemic: Insights from an Indian registry‐based observational study. Indian J Med Res 2021;153(5):619. https://doi.org/10.4103/ijmr.ijmr_1628_21
Portacci A, Carpagnano GE, Tummolo MG, et al. Covid‐19 clinical phenotypes and short‐term outcomes: Differences between the first and the second wave of pandemic in Italy. Expert Rev Respir Med 2021;15(12):1619‐1625. https://doi.org/10.1080/17476348.2021.1960824
Bhatnagar S, Sirohiya P, Elavarasi A, et al. Silent hypoxia in coronavirus disease‐2019: Is it more dangerous? A retrospective cohort study. Lung India 2022;39(3):247. https://doi.org/10.4103/lungindia. lungindia_601_21
Rahman S, Montero MT, Rowe K, Kirton R, Kunik F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID‐19: A review of current evidence. Expert Rev Clin Pharmacol 2021;14(5):601‐621. https://doi.org/10.1080/17512433.2021.1902303
Galanopoulos M, Gkeros F, Doukatas A, et al. Covid‐19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol 2020;26(31):4579‐4788. https://doi.org/10.3748/ wjg.v26.i31.4579
Maggialetti N, Villanova I, Castrì A, et al. Covid‐19 in Italy: Comparison of CT findings from Time Zero to the Delta variant. Microorganisms 2022;10(4):796. https://doi.org/10.3390/ microorganisms10040796
Alenezi FK, Almeshari MA, Mahida R, Bangash MN, Thickett DR, Patel JM. Incidence and risk factors of acute kidney injury in COVID‐19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID‐19: A systematic review and meta‐analysis. Renal Failure 2021;43(1):1621‐1633. https://doi.org/10.1080/0886022x.2021.2011747
Ronco C, Reis T. Kidney involvement in COVID‐19 and rationale for extracorporeal therapies. Nat Rev Nephrol 2020;16(6):308‐310. https://doi.org/10.1038/s41581‐020‐0284‐7
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS‐COV‐2 binds platelet ACE2 to enhance thrombosis in COVID‐19. J Hematol Oncol 2020 4;13(1). https://doi.org/10.1186/s13045‐020‐00954‐7 33. Nwagbara U, Osual E, Chireshe R, et al. Correction: Knowledge, attitude, perception, and preventative practices towards COVID‐19 in sub‐Saharan africa: A scoping review. PLoS ONE 2021;16(6). https://
doi.org/10.1371/journal.pone.0253833
Moodley SV, Zungu M, Malotle M, et al. A health worker knowledge, attitudes and practices survey of SARS‐COV‐2 infection prevention and control in South Africa. BMC Infect Dis 2021;21(1). https:// doi.org/10.1186/s12879‐021‐05812‐6
Downloads
Published
License
Copyright (c) 2024 O Hirachund, C Pennefather, M Naidoo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
